You are here

Article Text

Article menu
Download PDFPDF
Letter
Glib aside: sulphonylureas in advanced kidney disease
  1. James Shand1,
  2. Kate Bradley2
  1. 1 Departent of Geriatric Medicine, North Shore Hospital, Auckland, New Zealand
  2. 2 Department of General Medicine, Middlemore Hospital, Auckland, New Zealand
  1. Correspondence to Dr James Shand, North Shore Hospital, Auckland 0620, New Zealand; james.shand{at}waitematadhb.govt.nz

https://doi.org/10.1136/bmjebm-2020-111465

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Recent, BMJ Evidence Based Medicine (EBM) articles have highlighted a number of concerns pertaining to academic validity in medical guidelines. In the September 2019 issue, Braithwaite1 decried a ‘startling disconnect’ between EBM theory and the processes by which academic authorities accumulate and communicate evidence. Meanwhile, in the February 2020 issue, Bareket et al 2 noted the often inadvertent accumulation of error through authors ‘citing non-primary data and amplifying the errors of their predecessors’. Taken together, these procedural errors erode the academic backbone of medical guidelines and are thereby threaten the real-world foundation of evidence-based practice.3 However, these factors may be overlooked by the busy …

    View Full Text

    Footnotes

    • Contributors Both authors contributed equally to all facets of this project from design through to sign off of the completed product.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.